Gene: ANKDD1B
Official Full Name: ankyrin repeat and death domain containing 1Bprovided by HGNC
Gene Summary: Predicted to be involved in signal transduction. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19870 | ANKDD1B Knockout cell line (HCT 116) | Human | ANKDD1B | 1:2~1:4 | Negative | Online Inquiry |
ANKDD1B Gene Knockout Cell Lines are genetically modified cellular systems designed specifically to study the functions of the ANKDD1B gene, which is implicated in essential biological processes and various diseases. By utilizing CRISPR-Cas9 technology, these cell lines have undergone targeted gene editing to eliminate the expression of the ANKDD1B gene, allowing researchers to investigate the resulting phenotypic changes and molecular pathways involved. The precise knockout of this gene in a controlled cellular context enables a clearer understanding of its role in cellular functions such as signaling, differentiation, and response to external stimuli.
These cell lines serve as invaluable tools in both fundamental research and translational studies. They can be employed to assess the gene’s involvement in disease mechanisms, including cancer and genetic disorders, facilitating the identification of potential therapeutic targets. Additionally, researchers can utilize these knockout models to evaluate the efficacy of novel drug compounds and gene therapies, making them essential in preclinical research and drug discovery.
One of the key advantages of ANKDD1B Gene Knockout Cell Lines is their ability to provide consistent and reproducible results, which is critical for robust scientific findings. Unlike traditional methods that may produce variable outcomes, these cell lines offer a reliable platform for experimental manipulation and analysis. Furthermore, their compatibility with high-throughput screening assays increases their utility in large-scale studies.
For researchers and clinicians, the ANKDD1B Gene Knockout Cell Lines represent significant value through their potential to uncover novel insights into gene function and disease pathways. By elucidating the biological roles of the ANKDD1B gene, users can contribute to advancing the understanding of genetic conditions and improve therapeutic strategies.
Our company specializes in developing cutting-edge biological products and services, equipped with advanced technologies and a commitment to excellence in molecular biology research. This expertise underpins the quality of our knockout cell lines, ensuring that researchers and clinicians have access to reliable tools that facilitate groundbreaking discoveries and innovations in the life sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.